Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.

Holt TA, Hunter TD, Gunnarsson C, Khan N, Cload P, Lip GY.

Br J Gen Pract. 2012 Oct;62(603):e710-7. doi: 10.3399/bjgp12X656856.

2.

Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.

Mason PK, Lake DE, DiMarco JP, Ferguson JD, Mangrum JM, Bilchick K, Moorman LP, Moorman JR.

Am J Med. 2012 Jun;125(6):603.e1-6. doi: 10.1016/j.amjmed.2011.09.030. Epub 2012 Apr 11.

3.

Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.

Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.

PMID:
22268375
4.

Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population.

Poli D, Lip GY, Antonucci E, Grifoni E, Lane D.

J Cardiovasc Electrophysiol. 2011 Jan;22(1):25-30. doi: 10.1111/j.1540-8167.2010.01858.x.

PMID:
20653814
5.

Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.

Lip GY, Connolly S, Yusuf S, Shestakovska O, Flaker G, Hart R, Lanas F, Xavier D, Eikelboom J; ERROES Investigators.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):31-8. doi: 10.1161/CIRCEP.112.975847. Epub 2013 Feb 6.

6.

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.

Coppens M, Eikelboom JW, Hart RG, Yusuf S, Lip GY, Dorian P, Shestakovska O, Connolly SJ.

Eur Heart J. 2013 Jan;34(3):170-6. doi: 10.1093/eurheartj/ehs314. Epub 2012 Sep 27.

7.

Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.

Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26. doi: 10.1161/CIRCEP.111.966713. Epub 2012 Feb 8.

8.

Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.

Larsen TB, Lip GY, Skjøth F, Due KM, Overvad K, Hvilsted Rasmussen L.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):335-42. doi: 10.1161/CIRCOUTCOMES.111.964023. Epub 2012 Apr 24.

9.

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.

Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18. English, Spanish.

PMID:
22609214
10.

Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.

Giralt-Steinhauer E, Cuadrado-Godia E, Ois A, Jiménez-Conde J, Rodríguez-Campello Á, Soriano C, Roquer J.

Eur J Neurol. 2013 Apr;20(4):623-8. doi: 10.1111/j.1468-1331.2012.03807.x. Epub 2012 Jul 27.

PMID:
22834861
11.

Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke.

Navar-Boggan AM, Rymer JA, Piccini JP, Shatila W, Ring L, Stafford JA, Al-Khatib SM, Peterson ED.

Am Heart J. 2015 Jan;169(1):39-44.e2. doi: 10.1016/j.ahj.2014.09.014. Epub 2014 Oct 22.

PMID:
25497246
12.

Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.

Piccinocchi G, Laringe M, Guillaro B, Arpino G, Piccinocchi R, Nigro G, Calabrò P.

Clin Drug Investig. 2012 Nov;32(11):771-7. doi: 10.1007/s40261-012-0005-5.

13.

Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.

Bednarski J, Cieszewska E, Strzelecki A, Filipiak KJ.

Kardiol Pol. 2013;71(12):1260-5. doi: 10.5603/KP.a2013.0179. Epub 2013 Aug 30.

14.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

15.

[Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation].

Sun Y, Hu D; Chinese Investigators of GARFIELD; Chinese Investigators of GARFIELD.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Oct;42(10):846-50. Chinese.

PMID:
25549561
16.

CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.

Wasmer K, Köbe J, Dechering D, Milberg P, Pott C, Vogler J, Stypmann J, Waltenberger J, Mönnig G, Breithardt G, Eckardt L.

Clin Res Cardiol. 2013 Feb;102(2):139-44. doi: 10.1007/s00392-012-0507-4. Epub 2012 Sep 15.

PMID:
22983022
18.

Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

Olesen JB, Fauchier L, Lane DA, Taillandier S, Lip GY.

Chest. 2012 Jan;141(1):147-53. doi: 10.1378/chest.11-0862. Epub 2011 Jun 16.

PMID:
21680645
19.

Treatment pathways for patients with atrial fibrillation.

Hodgkinson JA, Taylor CJ, Hobbs FD.

Int J Clin Pract. 2012 Jan;66(1):44-52. doi: 10.1111/j.1742-1241.2011.02818.x. Erratum in: Int J Clin Pract. 2012 May;66(5):518.

PMID:
22171904
20.

Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.

Brandes A, Overgaard M, Plauborg L, Dehlendorff C, Lyck F, Peulicke J, Poulsen SV, Husted S.

Clin Cardiol. 2013 Jul;36(7):427-32. doi: 10.1002/clc.22133. Epub 2013 May 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk